Stories

Council member Menin of Manhattan is proposing a bill to ban the sale of disposable e-cigarettes, aiming to combat underage vaping. The move follows a ban on flavored vapes in 2020 and aims to prevent health risks associated with nicotine use among minors. Violators of the potential ban would face fines. Current lawsuits target distributors of colorful candy-flavored vapes, reflecting ongoing efforts to address teenage e-cigarette use. Data shows high usage rates among New York City students, highlighting the need for stricter regulations. Menin emphasizes the importance of safeguarding youth from nicotine exposure.

A total of 58 companies filed petitions for review regarding marketing denial orders (MDOs) with various circuit courts from 2021 onwards. These MDOs were subject to stays, reviews, and appeals, resulting in varied outcomes such as rescinded MDOs, administrative stays, court rulings in favor of petitioners, or denial of appeals. Major legal developments include the Supreme Court denying review requests, en banc rehearings, and amicus brief support. Companies like Bidi Vapor, R.J. Reynolds, and Triton Distribution had multiple appeals consolidated. As of October 2024, ongoing legal battles, such as the FDA's appeal of Triton Distribution's win, continue in different court circuits.

The vape industry in Malaysia faces challenges as Terengganu bans e-cigarette sales due to health concerns and youth marketing. Vape shops offering unique flavors like teh tarik have become popular, attracting former smokers. The health ministry warns of potential costs to treat vape-related lung injuries. Following the ban in Terengganu, the state government refuses to renew licenses for vape sales. Criticism arises after endorsing a vape-sponsored event. The ban reflects growing public health worries and youth protection.

The U.K. is set to ban disposable e-cigarettes to curb youth vaping and create a "smoke-free U.K." Disposable vapes are blamed for attracting young users with colorful flavors. Refillable vapes will still be sold. While the U.K. promotes e-cigarettes as a safer alternative to smoking, experts caution about potential health risks and addiction. The government also aims to reduce environmental impact, as millions of single-use vapes are discarded weekly. Critics warn against hindering access to vaping for adult smokers while tackling youth usage. In contrast to the U.K., the U.S. has seen a decline in youth vaping through campaigns and flavor bans, with the FDA approving certain e-cigarette products for smoking cessation.

Nicotine is often misunderstood as a carcinogen, but the US FDA clarifies that it's the harmful chemicals in tobacco products that cause health issues, not nicotine itself. UK's NHS also states that nicotine, though addictive, is relatively harmless. Nicotine is found not only in tobacco but also in other plants. Tobacco-related cancer is due to toxins from cigarette smoke. Safer alternatives like nicotine gums aim to reduce exposure to harmful substances. Experts support Nicotine Replacement Therapy to quit smoking. The global cancer burden is expected to rise significantly by 2050. Promoting these alternatives can be crucial in tobacco control policies for public health improvement.

The public health benefits of adopting a harm reduction approach to tobacco smoking are becoming increasingly evident. Countries that prioritize harm reduction in their anti-smoking strategies show better outcomes compared to those relying solely on traditional tobacco control methods. Sweden stands out as a key example, nearing the "smoke-free" benchmark of a smoking rate below 5%. This achievement is attributed to a mix of public education, tobacco control measures, and the availability of non-combustible alternatives to smoking.

Chris van Tulleken, Nigel Rollins, and Rebecca Coombes highlight the influence of industries on public health. Industries manipulate academia and health systems, hindering efforts to address health crises like smoking and unhealthy diets. The World Health Organization identifies these industries as commercial determinants of health, impacting people's well-being. Conflicts of interest among professionals and institutions, influenced by companies in sectors like food, alcohol, pharmaceuticals, and tobacco, must be addressed. Transparency and measures to mitigate biases are crucial in protecting public health. Collaborative efforts from governments, health authorities, and educators are needed to prioritize public health over corporate interests.

England is expected to miss its 2030 "smoke free" target by almost a decade, with Cancer Research UK predicting a 2039 achievement if current trends continue. The UK's smoking rates have declined, but England's progress is insufficient. Sweden and New Zealand are ahead due to successful tobacco alternatives. Government actions, such as banning disposable vapes and taxing vape products, may hinder efforts to reduce smoking rates. Critics argue that negative messaging around vaping contributes to the problem. CRUK supports legislation that opponents believe will impede smokers from transitioning to safer alternatives. The goal of a smoke-free UK by 2030 appears increasingly unlikely.

Despite progress in reducing smoking rates, disparities persist, with certain groups facing higher risk, as stated in a report by U.S. Surgeon General Vivek Murthy. Cigarette smoking kills nearly half a million annually in the U.S., with efforts needed to address disparities. The report recommends limiting nicotine in tobacco products and banning menthol cigarettes to save lives and curb smoking. However, the Biden administration delayed finalizing a menthol ban, drawing criticism from tobacco-control advocates. Measures including improving healthcare access and implementing smoke-free policies are suggested to reduce tobacco use. Despite public education efforts, the tobacco industry's marketing practices continue to pose challenges in combating smoking.

Varenicline, a highly effective smoking cessation pill, is back on the NHS after being withdrawn in 2021 due to impurities. A new version has been approved and can double or triple the chances of quitting compared to other methods. Varenicline works by blocking nicotine receptors in the brain, reducing cravings and withdrawal symptoms. It is estimated to help over 85,000 people quit smoking annually in the UK, potentially preventing 9,500 smoking-related deaths. While it can have side-effects like nausea, varenicline's benefits in improving public health make it a valuable tool in reducing smoking-related risks. Combining quitting aids with counselling enhances success rates. Support for quitting is available at www.nhs.uk/better-health/quit-smoking/.